摘要
目的探讨驻科临床药师参与尘肺并慢性阻塞性肺疾病(COPD)临床治疗的切入点。方法结合驻科药师工作实践,根据具体案例分析,介绍其在临床工作中的切入点,分析参与效果,并提出建议。结果驻科临床药师可通过制订个体化抗感染方案、关注患者的用药安全、提高药物有效性、调整用药方案、提高患者用药依从性、提示医师正确下达医嘱6个点切入尘肺并COPD患者的临床治疗。药师参与后,医院抗菌药物使用率、抗菌药物联用率、药师审核医嘱占比均显著降低(P<0.05),病原学送检率显著升高(P<0.05),且AUD由104降至53.32,降幅为48.73%。并通过开展疾病防治知识宣教,呼吸道用药指导及评估,问卷筛查及联合门诊,更广泛、更高质量地参与了相应患者的临床治疗。结论驻科临床药师的参与,可有效解决药物治疗过程中相关问题,优化医疗资源配置,提高整体医疗效率,有利于医疗资源得到更充分的利用。
Objective To analyze the entry point of clinical treatment of resident clinical pharmacists during the treatment of patients with pneumoconiosis complicated with chronic obstructive pulmonary disease(COPD).Methods Based on the work practice of resident clinical pharmacists and through specific case analysis,the entry points in clinical work were introduced,the effects of the resident clinical pharmacists′participation were analyzed,and suggestions were proposed.Results Resident clinical pharmacists could approach the clinical treatment of patients with pneumoconiosis complicated with COPD from six entry points as follows:developing individualized anti-infective schemes,focusing on patients′medication safety,enhancing drug effectiveness,adjusting medication schemes,improving patients′medication compliance,and advising physicians on the correct issuance of medical orders.After the participation of resident clinical pharmacists,the usage rate of antibacterial drugs,the rate of combined use of antibacterial drugs,and the proportion of prescriptions reviewed by pharmacists in the hospital were all significantly decreased(P<0.05).Meanwhile,the etiological submission rate was significantly increased(P<0.05),and the Antimicrobial Use Index(AUD)decreased from 104 to 53.32,with a reduction of 48.73%.Furthermore,through the implementation of disease prevention and control knowledge education,respiratory medication guidance and evaluation,questionnaire screening,and joint outpatient services,resident clinical pharmacists can participate in the clinical treatment of corresponding patients more extensively and with higher quality.Conclusion The participation of resident clinical pharmacists can effectively address issues related to the medication treatment process,optimize the allocation of medical resources,improve overall medical efficiency,and facilitate the fuller utilization of medical resources.
作者
马佳慧
赵悦
姜鹏
翁逸丹
朱泉合
MA Jiahui;ZHAO Yue;JIANG Peng;WENG Yidan;ZHU Quanhe(The Second Hospital of Heilongjiang Province,Harbin,Heilongjiang 150028,China)
出处
《中国药业》
2026年第8期141-146,共6页
China Pharmaceuticals
基金
黑龙江省卫生健康委科研课题[20241313050494]。
关键词
驻科药师
尘肺
慢性阻塞性肺疾病
药物治疗
药学服务
工作切入点
疾病管理
resident clinical pharmacist
pneumoconiosis
chronic obstructive pulmonary disease
medication
pharmaceutical care
entry point for work
disease management
